TrialBMC cancer2012

Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.

Falk Roeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.